Literature DB >> 2744957

The effect of long-term topical administration of commercial beta-blockers on the rat corneal endothelium.

M Matsuda1, Y Ishii, T Awata, M Fukuda.   

Abstract

To determine the effect of long-term topical application of commercial beta-blockers on the corneal endothelium, normal rats were randomly assigned to receive a drop of 0.5% timolol, 1% befunolol, or 2% carteolol four times daily for 8 months. Specular microscopy showed marked pleomorphism in the endothelium after three months of treatment with 1% befunolol. In contrast, the eyes treated with either 0.5% timolol or 2% carteolol demonstrated no significant change in endothelial morphology. Scanning and transmission electron microscopy at eight months after treatment revealed marked degeneration of the endothelium of the eyes treated with 1% befunolol. Similar endothelial changes were also noted in the 0.5% timolol-treated group, but to a significantly lesser extent. The eyes treated with 2% carteolol, however, showed only mild alteration of the endothelial ultrastructure. These results indicate that the corneal endothelium can be affected by long-term topical administration of commercial beta-blockers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744957     DOI: 10.1007/bf02028641

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  35 in total

1.  The effects of hard and soft contact lenses on the corneal endothelium.

Authors:  S M Mac Rae; M Matsuda; S Shellans; L F Rich
Journal:  Am J Ophthalmol       Date:  1986-07-15       Impact factor: 5.258

2.  Allergic conjunctivitis associated with timolol therapy in an adult.

Authors:  J A Baldone; J S Hankin; T J Zimmerman
Journal:  Ann Ophthalmol       Date:  1982-04

3.  Penetration of timolol into the rabbit eye. Measurements after ocular instillation and intravenous injection.

Authors:  C J Schmitt; V J Lotti; J C LeDouarec
Journal:  Arch Ophthalmol       Date:  1980-03

4.  Timolol inhibits corneal epithelial wound healing in rabbits and monkeys.

Authors:  T M Nork; F J Holly; J Hayes; T Wentlandt; D W Lamberts
Journal:  Arch Ophthalmol       Date:  1984-08

5.  Timolol, dose response and duration of action.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

6.  Adverse reactions from timolol administration.

Authors:  E M Van Buskirk
Journal:  Ophthalmology       Date:  1980-05       Impact factor: 12.079

7.  The place of timolol in the practice of ophthalmology.

Authors:  R P Wilson; G L Spaeth; E Poryzees
Journal:  Ophthalmology       Date:  1980-05       Impact factor: 12.079

8.  Ultrastructural effects of topical timolol on the rabbit cornea. Outcome alone and in conjunction with a gas permeable contact lens.

Authors:  B W Arthur; G J Hay; S M Wasan; W E Willis
Journal:  Arch Ophthalmol       Date:  1983-10

9.  The effects of aldose reductase inhibitor on the corneal endothelial morphology in diabetic rats.

Authors:  M Matsuda; T Awata; Y Ohashi; M Inaba; M Fukuda; R Manabe
Journal:  Curr Eye Res       Date:  1987-02       Impact factor: 2.424

10.  Pseudophakic bullous keratopathy. Relationship to preoperative corneal endothelial status.

Authors:  G N Rao; J V Aquavella; S H Goldberg; S L Berk
Journal:  Ophthalmology       Date:  1984-10       Impact factor: 12.079

View more
  1 in total

Review 1.  Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension.

Authors:  P Chrisp; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.